JENNIFER FORNICOLA: Open Payments
NPI 1003681487 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,473 in 63 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $442 · 2025 $1,473
Food & beverage: $1,473
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $426 |
| Janssen Biotech, Inc. | 11 | $248 |
| Madrigal Pharmaceuticals | 4 | $137 |
| QOL Medical, LLC | 4 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| PFIZER INC. | 4 | $73 |
| GENZYME CORPORATION | 2 | $72 |
| VIVUS LLC | 3 | $58 |
| Ardelyx, Inc. | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, Sucraid, DUPIXENT, ENTYVIO, LINZESS, CREON.
Industry payments across FL — which companies pay providers there.
